secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALLURION TECHNOLOGIES, INC. (ALUR)
CIK:        0001964979
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001193125-26-010462
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allurion Q4 revenue up 22-37% QoQ; FY2025 revenue ~$15M
-------------------------------------------------------

- Q4 2025 revenue $3.3-3.7M (22-37% QoQ increase); full-year revenue ~$15M.
- Substantial QoQ and YoY improvement in operating expenses and operating loss.
- CEO cites strategic pivot taking hold; potential FDA approval of Allurion Smart Capsule in 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1964979/000119312526010462/0001193125-26-010462-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1964979/000119312526010462/alur-20260112.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-010462

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer